Data / Form D filings / Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc.: Form D filings
Aegerion Pharmaceuticals, Inc., a pharmaceuticals company in Bridgewater, NJ, filed 3 Form D notices with the SEC between 2009 and 2010. The latest, on June 28, 2010, reports $18.3 million sold of a $19.8 million offering to 20 investors.
Find out what Aegerion Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1140 ROUTE 22 EAST, SUITE 304, Bridgewater, NJ, 08807
- Phone
- (908) 704-1300
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2005
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1338042
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 28, 2010 | Amendment | $19,814,760 | $18,314,760 | $1,500,000 | 20 | Sep 2, 2008 | sec.gov |
| Feb 9, 2010 | Amendment | $16,814,760 | $16,814,760 | $0 | 20 | Sep 2, 2008 | sec.gov |
| Jul 15, 2009 | Amendment | $15,814,760 | $13,562,101 | $2,252,659 | 20 | Sep 2, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David H. Scheer | Director | |
| Alison M. Kiley | Director | |
| Jason H. Fisherman | Director | |
| Peter M. Garrambone | Director | |
| William H. Lewis | Executive Officer | |
| Michele M. Ollier | Director | |
| Christine H. Pellizzari | Executive Officer | |
| Antonio M. Gotto | Director | |
| William H. Sasiela | Executive Officer |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Jun 28, 2010 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aegerion Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.